We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$169M
AUM Growth
+$6.16M
Cap. Flow
-$15.9M
Cap. Flow %
-9.4%
Top 10 Hldgs %
30.18%
Holding
221
New
53
Increased
41
Reduced
35
Closed
49

Top Buys

Rank Stock Value
1
CMBM
Cambium Networks
CMBM
+$2.89M
2
INDI icon
indie Semiconductor
INDI
+$2.88M
3
ASPN icon
Aspen Aerogels
ASPN
+$2.86M
4
SCPH
scPharmaceuticals
SCPH
+$2.68M
5
BDSX icon
Biodesix
BDSX
+$2.04M

Top Sells

Rank Stock Value
1
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$7.12M
2
MTRN icon
Materion
MTRN
+$4.81M
3
SEV
Sono Group N.V. Common Shares
SEV
+$2.22M
4
SIMO icon
Silicon Motion
SIMO
+$1.88M
5
TTGT icon
TechTarget
TTGT
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 21.33%
3 Financials 6.11%
4 Industrials 3.63%
5 Real Estate 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
151
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-14,200
Closed -$5K
BTU icon
152
PUT
Peabody Energy
BTU
$2.65B
– –
-19,800
Closed -$2K
CLNN icon
153
PUT
Clene
CLNN
$66.3M
– –
-2,005
Closed -$4K
CYTK icon
154
CALL
Cytokinetics
CYTK
$10.4B
– –
-20,000
Closed -$20K
FLEX icon
155
Flex
FLEX
$43B
– –
-13,270
Closed -$167K
GSK icon
156
CALL
GSK
GSK
$103B
– –
-39,900
Closed -$18K
HLIT icon
157
Harmonic Inc
HLIT
$1.28B
– –
-15,500
Closed -$203K
ICAD
158
DELISTED
iCAD Inc
ICAD
– –
-444,486
Closed -$933K
INVE icon
159
Identive
INVE
$64.8M
– –
-11,000
Closed -$138K
LLY icon
160
CALL
Eli Lilly
LLY
$1,000B
– –
-13,400
Closed -$20K
LOGI icon
161
PUT
Logitech
LOGI
$15.1B
– –
-21,000
Closed -$59K
MDGL icon
162
PUT
Madrigal Pharmaceuticals
MDGL
$11.1B
– –
-13,300
Closed -$49K
MRNA icon
163
PUT
Moderna
MRNA
$21.9B
– –
-13,400
Closed -$9K
MTRN icon
164
Materion
MTRN
$4.45B
– –
-60,079
Closed -$4.81M
MYO icon
165
Myomo
MYO
$40.2M
– –
-153,936
Closed -$249K
NLSPW
166
DELISTED
NLS Pharmaceutics Warrant
NLSPW
– –
-194,060
Closed -$49K
NTRA icon
167
PUT
Natera
NTRA
$38.7B
– –
-10,100
Closed -$5K
OEF icon
168
PUT
iShares S&P 100 ETF
OEF
$20.1B
– –
-102,500
Closed -$1.27M
PGRE
169
DELISTED
Paramount Group
PGRE
– –
-24,300
Closed -$151K
PXLW icon
170
Pixelworks
PXLW
$39.3M
– –
-31,775
Closed -$614K
RNAZ icon
171
TransCode Therapeutics
RNAZ
$4.47M
– –
0
– -$357K
SDS icon
172
ProShares UltraShort S&P500
SDS
$406M
– –
-1,200
Closed -$327K
SIMO icon
173
Silicon Motion
SIMO
$8.53B
– –
-28,835
Closed -$1.88M
SNY icon
174
Sanofi
SNY
$103B
– –
-16,572
Closed -$630K
TBX icon
175
ProShares Short 7-10 Year Treasury
TBX
$20.9M
– –
-8,000
Closed -$229K
4 5 6
7
8

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Worth Venture Partners held 221 positions worth $169M, up 3.8% from $163M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Worth Venture Partners withdrew a net $15.9M in Q4 2022, closing 49 positions and reducing 35 holdings. Its most notable exit was Materion, an estimated $4.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Worth Venture Partners opened a new position in Cambium Networks worth $3.11M.

  • Worth Venture Partners's largest Q4 2022 buy was Cambium Networks: 143,499 shares worth $3.11M.
  • Worth Venture Partners added most to indie Semiconductor in Q4 2022, an estimated $2.88M increase.
  • Worth Venture Partners's biggest Q4 2022 reduction was AVEO Pharmaceuticals, Inc., cutting an estimated $7.12M.
  • Worth Venture Partners fully exited Materion in Q4 2022, selling an estimated $4.81M.
  • Worth Venture Partners's ten largest holdings make up 30% of its $169M portfolio in Q4 2022.
  • Worth Venture Partners opened 53 new positions and closed 49 in Q4 2022.
  • Worth Venture Partners's portfolio value rose 3.8% quarter-over-quarter to $169M.

Based on Worth Venture Partners's 13F filing for Q4 2022, filed 14 Feb 2023.